American Well Corporation operates as an enterprise software platform company providing digital healthcare enablement solutions across the United States and internationally. The company's core offering is the Amwell Platform, a cloud-based system that facilitates hybrid care delivery across multiple settings, including virtual visits, in-person appointments, and automated care pathways. The company also offers Amwell Carepoint, which converts clinical devices and existing hardware into digital access points, and Amwell Converge, a platform designed to integrate digital care services with traditional clinical workflows.
Beyond its core platform, American Well provides specialty care programs in dermatology, musculoskeletal care, cardiology, and behavioral health services. The company operates Amwell Medical Group, a network offering primary care, urgent care, mental health therapy, and nutritional services. It additionally delivers professional services including implementation support, workflow design, and systems integration to facilitate customer adoption of its products.
American Well serves three primary customer categories: healthcare providers, insurance payers, and government entities, along with the higher education sector. The company distributes its solutions through direct field sales, channel partners, and value-added resellers. With 562 full-time employees and headquarters in Boston, Massachusetts, the company maintains operations across multiple geographies.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-5.96 | $-5.96 | +57.1% | |
| 2024 | $-13.88 | $-13.88 | -483.2% | |
| 2023 | $-2.38 | $-2.38 | -140.4% | |
| 2022 | $-0.99 | $-0.99 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-12 | 0001193125-26-048776 | SEC ↗ |
| 2024-12-31 | 2025-02-12 | 0000950170-25-019024 | SEC ↗ |
| 2023-12-31 | 2024-02-15 | 0000950170-24-015995 | SEC ↗ |
| 2022-12-31 | 2023-02-23 | 0000950170-23-003945 | SEC ↗ |
| 2021-12-31 | 2022-02-28 | 0001564590-22-007355 | SEC ↗ |
| 2020-12-31 | 2021-03-26 | 0001564590-21-015812 | SEC ↗ |